
Markets
Hantavirus vaccine in 2026?
$143K Vol.Jan 1, 20271 market
Yes
Loading…
MarketChanceBuy YesBuy No
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 P…

Hantavirus vaccine in 2026?
Yes · 3¢
Connect wallet to trade.
Order Book
connecting
Waiting for snapshot…
